> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Evidence-based Transplant Treatment Decisions
- URL: https://www.fdaweb.com/workshop-on-evidence-based-transplant-treatment-decisions/
- Published: 2018-09-12T12:00:00.000Z
- Updated: 2026-09-15T00:31:28.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142335

*Federal Register* notice: FDA has announced a public workshop entitled “Evidence-Based Treatment Decision in Transplantation: Patient Individualized Treatment; Choosing the Right Regimen for the Right Patient.” The workshop is intended to discuss potential candidate biomarkers to determine organ transplant patients’ immunologic risk for organ rejection or tolerance. It will include discussion of the biomarker qualification process and how it could be used to develop biomarkers for use in clinical trials in transplantation, to develop new drugs to address unmet needs, and in clinical practice to guide patient treatment selection. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-09-12/pdf/2018-19816.pdf?ref=fdaweb.com).